Legal Representation
Attorney
Charles R Halloran
USPTO Deadlines
Next Deadline
445 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20170307)
Due Date
March 07, 2027
Grace Period Ends
September 07, 2027
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 26, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 26, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 26, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 16, 2023 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Aug 16, 2023 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Aug 16, 2023 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Feb 17, 2023 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Mar 7, 2022 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jul 7, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jun 7, 2018 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Nov 3, 2017 | COC. | O | CORRECTION UNDER SECTION 7 - PROCESSED | Loading... |
| Nov 3, 2017 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Apr 28, 2017 | ES7R | I | TEAS SECTION 7 REQUEST RECEIVED | Loading... |
| Mar 7, 2017 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 31, 2017 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| Jul 28, 2016 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Jul 19, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 19, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 29, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 13, 2016 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jun 7, 2016 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 7, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 7, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 2, 2016 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 19, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 13, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 13, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 13, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 13, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 7, 2015 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 6, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 3, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical [ and veterinary ] preparations for treatment of central nervous system diseases, cancer and metabolic diseases; [ sanitary preparations for medical use; biological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; ] chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases [ ; medical preparation of trace elements for human and animal use, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; ferments for pharmaceutical purposes; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; blood solvent; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity adjustment; vitamin preparations; vaccines; dietary supplements; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; bacteriological preparations for medical and veterinary use ]
Additional Information
Design Mark
The mark consists of the letters "SK" in red stylized font and the letters "biotek" in orange stylized font; to the top right of the "SK" portion of the mark is a design of wings; the inner portion of the wings is red, and the outer portion of the wings is orange; white is not claimed as a feature of the mark and only represents background or transparent areas.
Color Claim
The color(s) red and orange is/are claimed as a feature of the mark.
Other
In the statement, line 26, "12-02-2025" should be deleted, and "12-07-2025" should be inserted.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTECH"